mefenamic acid has been researched along with levonorgestrel in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Duckitt, K; Shaw, RW | 1 |
| Jaisamraun, U; Kaewrudee, S; Reinprayoon, D; Taneepanichskul, S | 1 |
| Reid, PC; Virtanen-Kari, S | 1 |
| Daniels, J; Gray, R; Gupta, J; Kai, J; Middleton, L; Pattison, H | 1 |
| Soper, DE | 1 |
| Draeby, J; Inki, P; O'Flynn, M; Schmelter, T; Sørdal, T | 1 |
| Bofill Rodriguez, M; Brown, J; Lethaby, A; Weterings, MA; Wise, MR | 1 |
| Bofill Rodriguez, M; Jordan, V; Lethaby, A | 1 |
3 review(s) available for mefenamic acid and levonorgestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Combined hormonal contraceptives for heavy menstrual bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Danazol; Drug Therapy, Combination; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Naproxen; Nausea; Placebos; Progestins; Randomized Controlled Trials as Topic | 2019 |
Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Topics: Antifibrinolytic Agents; Contraceptives, Oral; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Norethindrone; Progesterone; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome | 2020 |
4 trial(s) available for mefenamic acid and levonorgestrel
| Article | Year |
|---|---|
The effect of mefenamic acid on controlling irregular uterine bleeding secondary to Norplant use.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Double-Blind Method; Endometrium; Estradiol; Female; Fluoroimmunoassay; Humans; Levonorgestrel; Mefenamic Acid; Progesterone; Ultrasonography; Uterine Hemorrhage | 1999 |
Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medical Records; Mefenamic Acid; Menorrhagia; Menstruation; Middle Aged; Treatment Outcome | 2005 |
Levonorgestrel intrauterine system versus medical therapy for menorrhagia.
Topics: Adult; Antifibrinolytic Agents; Contraceptive Agents, Female; Estrogens; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Progestins; Quality of Life; Severity of Illness Index; Sexual Behavior; Tranexamic Acid | 2013 |
Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Prospective Studies; Tranexamic Acid | 2013 |
5 other study(ies) available for mefenamic acid and levonorgestrel
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Is medical management of menorrhagia obsolete?
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Estrogen Replacement Therapy; Female; Humans; Hysteroscopy; Laparoscopy; Levonorgestrel; Mefenamic Acid; Menorrhagia; Middle Aged; Norethindrone; Progesterone Congeners; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Tranexamic Acid | 1998 |
The intrauterine device: a good thing revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; Biomedical Research; Breast Neoplasms; Contraceptive Agents, Female; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Mefenamic Acid; Metrorrhagia; Pelvic Inflammatory Disease; Tamoxifen; Tranexamic Acid | 2013 |